Pharmaceutical

South Korean company Dong-A ST wins FDA approval for Stelara biosimilar

Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for the treatment of certain autoimmune diseases.

Oct 12, 2024 - 04:00
South Korean company Dong-A ST wins FDA approval for Stelara biosimilar
Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for the treatment of certain autoimmune diseases.
Read the original article

Tags:

Previous Article

Scholar Rock’s Phase 3 SMA Trial Achieves Success

Next Article

FDA AdCom votes in favour of Stealth’s Barth syndrome drug

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Machine learning could help predict risk of preterm birth using wearables data

Machine learning could help predict risk of preterm bir...

Sep 28, 2023

STAT+: FDA approves Medtronic high blood pressure device despite a negative advisory panel vote

STAT+: FDA approves Medtronic high blood pressure devic...

Nov 17, 2023

Novaliq pursues EMA approval for dry eye disease drug

Novaliq pursues EMA approval for dry eye disease drug

Aug 24, 2023